Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Ariad Pharmaceuticals Inc (ARIA)  
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 185,611,000
Market Cap: N/A
Last Volume: 6,246,627 Avg Vol: 2,834,746
52 Week Range: $23.99 - $23.99
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile  


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-03-10 2023-12-08 2023-06-09 2022-06-09

   
Records found: 703
  Page 19 of 29  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Keane Raymond T SVP General Counsel & CCO   •       •      –    2012-08-15 4 OE $2.39 $23,900 D/D 10,000 49,280     -
   Clackson Timothy P President, R&D, CSO   •       •      –    2012-08-15 4 AS $20.00 $736,860 D/D (36,843) 234,169     -
   Clackson Timothy P President, R&D, CSO   •       •      –    2012-08-15 4 OE $7.56 $278,533 D/D 36,843 271,012     -
   Bollag Daniel M Sr. VP, Reg. Affairs & Quality   •       •      –    2012-07-30 4 AS $19.00 $142,500 D/D (7,500) 85,519     -
   Bollag Daniel M Sr. VP, Reg. Affairs & Quality   •       •      –    2012-07-30 4 OE $1.30 $9,750 D/D 7,500 93,091     -
   Keane Raymond T SVP General Counsel & CCO   •       •      –    2012-07-30 4 AS $19.00 $190,000 D/D (10,000) 39,280     -
   Dodion Pierre F SVP, Corp. Dev. & Operations   •       •      –    2012-07-30 4 AS $19.00 $543,400 D/D (28,600) 33,040     -
   Dodion Pierre F SVP, Corp. Dev. & Operations   •       •      –    2012-07-30 4 OE $5.49 $137,250 D/D 25,000 61,640     -
   Berstein David L Senior VP, Chief IP Officer   •       •      –    2012-07-30 4 AS $19.00 $152,000 D/D (8,000) 221,856     -
   Clackson Timothy P President, R&D, CSO   •       •      –    2012-07-30 4 AS $19.00 $441,446 D/D (23,234) 234,169     -
   Clackson Timothy P President, R&D, CSO   •       •      –    2012-07-30 4 OE $5.23 $121,514 D/D 23,234 257,403     -
   Cantor Maria E SVP, Corporate Affairs   •       •      –    2012-07-30 4 AS $19.00 $123,082 D/D (6,478) 32,848     -
   Cantor Maria E SVP, Corporate Affairs   •       •      –    2012-07-30 4 OE $7.82 $50,658 D/D 6,478 39,326     -
   Keane Raymond T SVP General Counsel & CCO   •       •      –    2012-07-26 4 AS $18.00 $180,000 D/D (10,000) 49,280     -
   Keane Raymond T SVP General Counsel & CCO   •       •      –    2012-07-26 4 OE $2.39 $23,900 D/D 10,000 59,280     -
   Lavidas Athanese Director   •       •      –    2012-07-20 4 AS $18.00 $89,977 D/D (5,000) 90,631     -
   Fitzgerald Edward M Executive VP, CFO   •       •      –    2012-07-02 4 AS $17.64 $440,950 D/D (25,000) 204,767     -
   Cantor Maria E SVP, Corporate Affairs   •       –      –    2012-06-25 4 AS $17.11 $30,199 D/D (1,765) 32,337     -
   Bollag Daniel M Sr. VP, Reg. Affairs & Quality   •       –      –    2012-06-22 4 AS $17.50 $131,270 D/D (7,500) 85,095     -
   Bollag Daniel M Sr. VP, Reg. Affairs & Quality   •       –      –    2012-06-22 4 OE $1.30 $9,750 D/D 7,500 92,595     -
   Lavidas Athanese Director   –       •      –    2012-06-20 4 AS $17.41 $87,028 D/D (5,000) 95,631     -
   Cantor Maria E SVP, Corporate Affairs   •       –      –    2012-06-19 4 AS $18.00 $135,000 D/D (7,500) 34,102     -
   Cantor Maria E SVP, Corporate Affairs   •       –      –    2012-06-19 4 OE $3.08 $23,100 D/D 7,500 41,602     -
   Berger Harvey J MD Chairman & CEO   •       •      –    2012-06-13 4 D $16.79 $99,984 D/D (5,955) 2,189,683     -
   Berger Harvey J MD Chairman & CEO   •       •      –    2012-06-13 4 OE $4.05 $99,999 D/D 24,691 2,195,638     -
  703 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 19 of 29
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us